Learn more

UNIV NEWCASTLE RES ASS

Overview
  • Total Patents
    255
About

UNIV NEWCASTLE RES ASS has a total of 255 patent applications. Its first patent ever was published in 1976. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, chemical engineering and measurement are BETZ MICHAEL, BIOTECON GES FUER BIOTECHNOLOGISCHE ENTWICKLUNG & CONSULTING MBH and PICOWER INST MED RES.

Patent filings per year

Chart showing UNIV NEWCASTLE RES ASSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Jameson Graeme John 44
#2 Mccluskey Adam 18
#3 Gleeson Maree 18
#4 Clancy Robert Llewellyn 15
#5 Galvin Kevin Patrick 12
#6 Clancy Robert 12
#7 Jameson Graeme J 10
#8 Lambert Noel William Alexander 9
#9 Ackland Stephen 9
#10 Batey Robert 7

Latest patents

Publication Filing date Title
WO2008064406A1 Method of operating an inclined plate classifier
US2007292971A1 Method of determining potential susceptibility to development of ALTE and/or SIDS
WO2008064393A1 Treatment for envenomation
WO2007128062A1 Desalination method and apparatus
CA2586748A1 Agents for prophylaxis or treatment of neurological diseases and conditions
WO2007062458A1 Anti-spatter formulation
WO2007048192A1 Gassing of emulsion explosives with nitric oxide
EP1914548A1 Method for identifying women with an increased risk of preterm delivery
EP1914553A1 Method for identifying women with an increased risk of foetal growth retardation
EP1914552A1 Method for identifying women with an increased risk of pre-eclampsia
WO2007033415A1 A method of analysis and an analyser
WO2007014430A1 Game apparatus
WO2006119567A1 Building cladding element with built in passive solar efficiency
CA2543108A1 Dust reduction in delivery of particulate commodities
WO2006081611A1 Method and apparatus for contacting bubbles and particles in a flotation separation system
WO2005106965A1 Multicomponent organic solar cells
EP1725256A1 A vaccine formulated for administration to mucosa of the lungs
AU2005211836A1 A vaccine formulated for administration to mucosa of the lungs
WO2005049009A1 Methods and agents for inhibiting dynamin-dependent endocytosis
AU2004290467A1 Methods and agents for inhibiting dynamin-dependent endocytosis